Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Collado

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Reumatologia Clinica|May 1, 2021
Recommendations by the Spanish Society of Rheumatology on Fibromyalgia. Part 1: Diagnosis and TreatmentJavier Rivera Redondo, Petra Díaz Del Campo Fontecha, Cayetano Alegre de Miquel, et al.
Reumatologia Clinica|May 2, 2021
Recommendations by the Spanish Society of Rheumatology on the Management of Patients with Fibromyalgia. Part IIJavier Rivera Redondo, Petra Díaz Del Campo Fontecha, Cayetano Alegre de Miquel, et al.
Plos One|April 30, 2015
Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and EfficacyKarin Neukam, Daniela I Munteanu, Antonio Rivero-Juárez, et al.
Reumatologia Clinica|September 20, 2021
Recommendations by the Spanish Society of Rheumatology on the management of patients with fibromyalgia. Part IIJavier Rivera Redondo, Petra Díaz Del Campo Fontecha, Cayetano Alegre de Miquel, et al.
Plos One|May 20, 2016
Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic StudyKarin Neukam, Nuria Espinosa, Antonio Collado, et al.
Plos One|January 20, 2026
Correction: Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trialSergio Sequera-Arquelladas, María J Vivancos, David Vinuesa, et al.
Plos One|September 22, 2025
Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trialSergio Sequera-Arquelladas, María J Vivancos, David Vinuesa, et al.
International Journal of Antimicrobial Agents|April 4, 2024
Bictegravir/emtricitabine/tenofovir alafenamide as first-line treatment in naïve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trialCarmen Hidalgo-Tenorio, Sergio Sequera, María Jesus Vivancos, et al.
The Journal of Antimicrobial Chemotherapy|October 16, 2008
Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backboneJosé A Mira, Luis F López-Cortés, Pablo Barreiro, et al.
Plos One|August 31, 2019
Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohortAna Belén Pérez, Natalia Chueca, Juan Macías, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Reumatologia Clinica|May 1, 2021
Recommendations by the Spanish Society of Rheumatology on Fibromyalgia. Part 1: Diagnosis and TreatmentJavier Rivera Redondo, Petra Díaz Del Campo Fontecha, Cayetano Alegre de Miquel, et al.
Reumatologia Clinica|May 2, 2021
Recommendations by the Spanish Society of Rheumatology on the Management of Patients with Fibromyalgia. Part IIJavier Rivera Redondo, Petra Díaz Del Campo Fontecha, Cayetano Alegre de Miquel, et al.
Plos One|April 30, 2015
Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and EfficacyKarin Neukam, Daniela I Munteanu, Antonio Rivero-Juárez, et al.
Reumatologia Clinica|September 20, 2021
Recommendations by the Spanish Society of Rheumatology on the management of patients with fibromyalgia. Part IIJavier Rivera Redondo, Petra Díaz Del Campo Fontecha, Cayetano Alegre de Miquel, et al.
Plos One|May 20, 2016
Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic StudyKarin Neukam, Nuria Espinosa, Antonio Collado, et al.
Plos One|January 20, 2026
Correction: Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trialSergio Sequera-Arquelladas, María J Vivancos, David Vinuesa, et al.
Plos One|September 22, 2025
Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trialSergio Sequera-Arquelladas, María J Vivancos, David Vinuesa, et al.
International Journal of Antimicrobial Agents|April 4, 2024
Bictegravir/emtricitabine/tenofovir alafenamide as first-line treatment in naïve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trialCarmen Hidalgo-Tenorio, Sergio Sequera, María Jesus Vivancos, et al.
The Journal of Antimicrobial Chemotherapy|October 16, 2008
Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backboneJosé A Mira, Luis F López-Cortés, Pablo Barreiro, et al.
Plos One|August 31, 2019
Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohortAna Belén Pérez, Natalia Chueca, Juan Macías, et al.
Pageof 8